Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Drugs Made In America Acquisition II Corp. - Unit (DMIIU)
Company Research
Source: GlobeNewswire
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted company, today announced that commencing December 3, 2025, holders of the units sold in the Company’s initial public offering completed on September 26, 2025, may elect to separately trade the ordinary shares of the Company and the rights included in such units on the Nasdaq Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”). Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The ordinary shares and rights that are separated will trade on Nasdaq under the symbols “DMII” and “DMIIR,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “DMIIU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Compa
Show less
Read more
Impact Snapshot
Event Time:
DMIIU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DMIIU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DMIIU alerts
High impacting Drugs Made In America Acquisition II Corp. - Unit news events
Weekly update
A roundup of the hottest topics
DMIIU
News
- Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company [Yahoo! Finance]Yahoo! Finance
- Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025 [Yahoo! Finance]Yahoo! Finance
- Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public OfferingGlobeNewswire
- Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public OfferingGlobeNewswire
DMIIU
Sec Filings
- 11/18/25 - Form 10-Q
- 11/18/25 - Form 8-K
- 11/17/25 - Form NT
- DMIIU's page on the SEC website